The Evolution of Vpr/Vpx Function in Primate Lentiviruses
The Evolution of Vpr/Vpx Function in Primate Lentiviruses
批准号:
8708171
负责人:
Michael Emerman
金额:
$32.41万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-01 至 2017-07-31
关键词:
AddressAffectAntiviral AgentsBiologyCell CycleCellsCercopithecus pygerythrusDataDendritic CellsEvolutionG2 PhaseGenesGenetic PolymorphismGenomeGrantHIVHIV therapyHIV-1HIV-2Host DefenseHumanIndividualInfectionInterventionModelingMolecularNatureNucleotidesPharmaceutical PreparationsPopulationPrimate LentivirusesPrimatesProteinsRaceRelative (related person)RestSourceSpecificitySubfamily lentivirinaeT-LymphocyteTestingViralViral GenesVirusVirus Replicationarmbasein vivomacrophagemonocytenovelpandemic diseasepathogenprotein degradationpublic health relevanceresearch studytooltransmission processvirus host interactionvpr Gene Productsvpr Genes
中文摘要
描述(申请人提供):HIV-1和其他灵长类慢病毒编码辅助基因,用于增强病毒复制和对抗宿主抗病毒因子。这些限制因素具有限制病毒复制和影响慢病毒跨物种传播的能力。此外,病毒辅助蛋白和宿主限制因子之间的相互作用是HIV治疗的新药物干预的潜在来源。VPX和VPR是两种相关的慢病毒辅助蛋白。虽然所有灵长类慢病毒都编码Vpr,但只有两种病毒也编码Vpx。VPX对灵长类慢病毒有效感染单核细胞、树突状细胞、巨噬细胞和静息T细胞的能力至关重要,而VPR具有许多公认的功能,包括将细胞阻止在细胞周期的G2期。最近,VPX的靶标被确定为宿主限制因子SAMHD1,它是VPX降解的靶标。对VPX和VPR功能关系的进化分析表明,VPX和VPR的功能存在重叠。来自不同慢病毒的VPX蛋白以及来自某些慢病毒的VPR蛋白都具有针对其宿主物种的SAMHD1进行降解的能力。然而,HIV-1VPR不与SAMHD1相互作用,因此这种病毒-宿主相互作用的重要性仍然是一个谜。在这笔赠款中,我们将通过研究非洲绿猴及其慢病毒感染的自然感染研究中宿主-病毒的进化来确定SAMHD1相互作用的重要性。此外,我们将通过确定来自不同灵长类宿主的SAMHD1蛋白被不同的VPX/VPR蛋白识别的分子基础,来确定VPX/VPR和SAMHD1是如何共同进化来识别和逃避彼此的。我们还将研究来自人类病原体HIV-2的VPX与人类SAMHD1的相互作用,并将探索一些HIV-1毒株也编码能够降解SAMHD1的VPR蛋白的可能性。最后,我们将通过确定VPR的祖先功能和一些VPR蛋白如何具有多种功能来检验这一假设,即VPR和VPX的新功能是在现有功能的基础上进化出来的。
英文摘要
DESCRIPTION (provided by applicant): HIV-1 and other primate lentiviruses encode accessory genes that serve to enhance virus replication and counteract host antiviral factors. These restriction factors have the capacity to limit virus replication and influence cross-species transmissions of lentiviruses. Moreover, the interactions between viral accessory proteins and host restriction factors are a potential source of novel drug interventions for HIV therapy. Vpx and Vpr are two related lentiviral accessory proteins. While all primate lentiviruses encode Vpr, only two of them encode Vpx as well. Vpx is critical for the ability of primate lentiviruses to efficiently infect monocytes, dendritic cells, macrophages, and resting T cells, while Vpr has many ascribed functions including the ability to arrest cells in the G2 phase of the cell cycle. Recently, the target of Vpx has been identified as the host restriction factor SAMHD1 which is targeted for degradation by Vpx. An evolutionary analysis to understand the functional relationship of Vpx and Vpr showed that Vpx and Vpr have overlapping functions. Vpx proteins from diverse lentiviruses as well as Vpr proteins from some lentiviruses both have the ability to target their host species' SAMHD1 for degradation. However, HIV-1 Vpr does not interact with SAMHD1, and therefore the importance of this virus-host interaction remains a mystery. In this grant we will determine the importance of the SAMHD1 interaction by examining the host-virus evolution in a natural infection study of African green monkeys and their lentirviral infections. Furthermore, we will determine how Vpx/Vpr and SAMHD1 have co-evolved to recognize and escape each another by determining the molecular basis by which SAMHD1 proteins from different primate hosts are recognized by different Vpx/Vpr proteins. We will also examine the interactions of Vpx from a human pathogen, HIV-2 with human SAMHD1 and will explore the possibility that some HIV-1 strains also encode a Vpr protein that is capable of degrading SAMHD1. Finally, we will test the hypothesis that new functions for Vpr and Vpx have evolved on top off pre-existing functions by determining the ancestral function of Vpr and by determining how some Vpr proteins can have multiple functions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIV-CRISPR: A novel approach to the comprehensive discovery of HIV latency factors
-
批准号:10642658
-
项目类别:
-
资助金额:$88.0万
-
财政年份:2020
-
负责人:Michael Emerman
-
依托单位:
HIV-CRISPR: A novel approach to the comprehensive discovery of HIV latency factors
-
批准号:10371192
-
项目类别:
-
资助金额:$88.0万
-
财政年份:2020
-
负责人:Michael Emerman
-
依托单位:
The Evolution of Vpr/Vpx Function in Primate Lentiviruses
-
批准号:9111946
-
项目类别:
-
资助金额:$32.14万
-
财政年份:2013
-
负责人:Michael Emerman
-
依托单位:
The Evolution of Vpr/Vpx Function in Primate Lentiviruses
-
批准号:8602705
-
项目类别:
-
资助金额:$32.52万
-
财政年份:2013
-
负责人:Michael Emerman
-
依托单位:
HIV Infection of Non-Dividing Cells
-
批准号:7923049
-
项目类别:
-
资助金额:$20.66万
-
财政年份:2009
-
负责人:Michael Emerman
-
依托单位:
Characterization of Super Restriction Factors and Prediction of Host-HIV Interfaces
-
批准号:10229575
-
项目类别:
-
资助金额:$48.92万
-
财政年份:2007
-
负责人:Michael Emerman
-
依托单位:
HIV Infection of Non-Dividing Cells
-
批准号:7638581
-
项目类别:
-
资助金额:$29.7万
-
财政年份:2007
-
负责人:Michael Emerman
-
依托单位:
HIV Infection of Non-Dividing Cells
-
批准号:7879997
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2007
-
负责人:Michael Emerman
-
依托单位:
HIV Infection of Non-Dividing Cells
-
批准号:7339109
-
项目类别:
-
资助金额:$30.28万
-
财政年份:2007
-
负责人:Michael Emerman
-
依托单位:
HIV Infection of Non-Dividing Cells
-
批准号:7452207
-
项目类别:
-
资助金额:$29.7万
-
财政年份:2007
-
负责人:Michael Emerman
-
依托单位:
Accessory roles of Tat in HIV-1 replication
-
批准号:6450172
-
项目类别:
-
资助金额:$29.81万
-
财政年份:2002
-
负责人:Michael Emerman
-
依托单位:
Accessory roles of Tat in HIV-1 replication
-
批准号:6622534
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2002
-
负责人:Michael Emerman
-
依托单位:
Accessory roles of Tat in HIV-1 replication
-
批准号:6725503
-
项目类别:
-
资助金额:$29.78万
-
财政年份:2002
-
负责人:Michael Emerman
-
依托单位:
Accessory roles of Tat in HIV-1 replication
-
批准号:6876049
-
项目类别:
-
资助金额:$29.76万
-
财政年份:2002
-
负责人:Michael Emerman
-
依托单位:
VPR AND HIV INFECTION
-
批准号:6631908
-
项目类别:
-
资助金额:$43.25万
-
财政年份:1991
-
负责人:Michael Emerman
-
依托单位:
VPR AND HIV INFECTION
-
批准号:6169648
-
项目类别:
-
资助金额:$34.11万
-
财政年份:1991
-
负责人:Michael Emerman
-
依托单位:
VPR AND HIV INFECTION
-
批准号:6510611
-
项目类别:
-
资助金额:$43.25万
-
财政年份:1991
-
负责人:Michael Emerman
-
依托单位:
HIV Host-Cell Interactions
-
批准号:7425068
-
项目类别:
-
资助金额:$48.53万
-
财政年份:1991
-
负责人:Michael Emerman
-
依托单位:
HIV Host-Cell Interactions
-
批准号:9889015
-
项目类别:
-
资助金额:$52.31万
-
财政年份:1991
-
负责人:Michael Emerman
-
依托单位:
HIV HOST-CELL INTERACTIONS
-
批准号:2065989
-
项目类别:
-
资助金额:$1.44万
-
财政年份:1991
-
负责人:Michael Emerman
-
依托单位:
海外基金